Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LAS VEGAS, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Marathon Patent Group, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), one of the largest enterprise Bitcoin self-mining companies in North America, today...
-
Oakland, CA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Reading Partners, an early literacy nonprofit dedicated to mobilizing community volunteers to tutor students attending under-resourced schools,...
-
LOS ANGELES, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Playboy Enterprises, Inc. (the “Company” or “Playboy”), one of the largest and most recognizable lifestyle brands in the world, today announced that it...
-
GREENWICH, Conn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCO) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (“Oxford Lane,” the “Company,” “we,” “us” or...
-
SECAUCUS, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- The Children’s Place, Inc. (Nasdaq: PLCE), the largest pure-play children’s specialty apparel retailer in North America, today announced that Robert...
-
København Ø, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Bestyrelsen har vedtaget at foretage aconto-udlodning i Investeringsforeningen Alm. Brand Invest som det fremgår af nedenstående. ...
-
Junshi Biosciences to receive up to an aggregate of US$1.11 billion of upfront payment, exercise fee and milestone payments from Coherus for the grant of the license of toripalimab and the two option...
-
København Ø, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Bestyrelsen har vedtaget at foretage aconto-udlodning i Kapitalforeningen BankInvest Select som det fremgår af nedenstående. ...
-
København Ø, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Bestyrelsen har vedtaget at foretage aconto-udlodning i Investeringsforeningen BankInvest, som det fremgår af nedenstående. Udbytterne vil...
-
AGOURA HILLS, California, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious diseases,...